A small prospective study of chordomas treated with radiotherapy and razoxane

Strahlentherapie und Onkologie

Volumn 179, Issue 4, 2003, Pages 249-253

  Rhomberg, Walter ^a   Böhler, Franz Karl ^a   Novak, Hansjörg ^a   Dertinger, Susanne ^a   Breitfellner, Gerhard ^a  

^a GENERAL HOSPITAL   (Austria)

Author keywords

Chordomas; Combined modality treatment; Radiation therapy; Radiosensitizing agents; Razoxane

Indexed keywords

RAZOXANE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHONDROSARCOMA; CHORDOMA; CLINICAL ARTICLE; COBALT TELETHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEART FAILURE; HISTOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON; RADIATION DOSE; SKULL BASE; SOFT TISSUE; SPINE; TUMOR REGRESSION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHORDOMA; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; PHOTONS; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY DOSAGE; RAZOXANE; SACRUM; SKULL BASE NEOPLASMS; SPINAL NEOPLASMS; THORACIC VERTEBRAE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0345700685     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-003-1052-x     Document Type: Article

References (38)

1. Austin JP, Urie MM, Cardenosa G, Munzenrider JE. Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine. Int J Radiat Oncol Biol Phys 1993;25:439-44.
2. Bakowski, MT. ICRF 159, +/- 1,2-di (3,5-dioxopiperazinyl)-propane; NSC 129943; razoxane. Cancer Treat Rev 1976;3:95-107.
3. Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 1995;31:577-81.
4. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine. A study of 39 patients. Cancer 2000;88:2122-34.
5. Berson AM, Castro JR, Petti P, Phillips TL, Gauger GE, Gutin P, Collier JM, Henderson SD, Baken K. Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience. Int J Radiat Oncol Biol Phys 1988;15:559-65.
6. Catton C, O'Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V, Wunder J. Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 1996;41:67-72.
7. Chetty R, Levin CV, Kalan MR. Chordoma: a 20-year clinicopathologic review of the experience at Groote Schuur Hospital, Cape Town. J Surg Oncol 1991;46:261-4.
8. Cummings BJ, Hodson I, Bush RS. Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys 1983;9:633-42.
9. Debus J, Haberer T, Schulz-Ertner D, Jakel O, Wenz F, Enghardt W, Schlegel W, Kraft G, Wannenmacher M. Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives. Strahlenther Onkol 2000;176:211-6.
10. Debus J, Schulz-Ertner D, Schad L, Essig M, Rhein B, Thillmann CO, Wannenmacher M. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 2000;47:591-6.
11. De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer principles & practice of oncology, 4th edn. Philadelphia: Lippincott, 1993:1726-7.
12. Fabrizio PL, Schild SE, Stafford SL, Davis DH, Schomberg PJ. Irradiation for craniospinal chordomas. Proceedings of the 41st Annual ASTRO Meeting. Int J Radiat Oncol Biol Phys 1999;47:Suppl 1:327.
13. Fuller DB, Bloom JG. Radiotherapy for chordoma. Int J Radiat Oncol Biol Phys 1988;15:331-9.
14. Glanzmann Ch, Horst W. Ergebnisse der Strahlentherapie bei Chordomen. Strahlentherapie 1978;154:85-8.
15. Hellmann K, James SE, Salsbury AJ. Analysis of the antimetastatic action of the antimitotic agent ICRF 159. Br J Cancer 1974;30:179.
16. Hellmann K, Murkin GE. Synergism of ICRF 159 and radiotherapy in the treatment of experimental tumors. Cancer 1974;34:1033-9.
17. Hellmann K, Rhomberg W. Radiotherapeutic enhancement by razoxane. Cancer Treat Rev 1992;18:225-40.
18. Hug EB, Loredo LN, Slater JD, DeVries A, Grove RI, Schaefer RA, Rosenberg AE, Slater JM. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999;91:432-9.
19. Hug EB, Muenter MW, Adams JA, de Vries A, Rosenberg AE, Munzenrider JE. 3-D-conformal radiation therapy for pediatric giant cell tumors of the skull base. Strahlenther Onkol 2002;178:239-44.
20. Keisch ME, Garcia DM, Shibuya RB. Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution. J Neurosurg 1991;75:374-7.
21. Latz D, Gademann G, Hawighorst H, Engenhart R, van Kaick G, Wannenmacher M. First results with fractionated three-dimensional stereotactic radiotherapy of chordomas located at the clivus. Stahlenther Onkol 1995; 171:348-55.
22. Le Serve AW, Hellmann K. Metastases and the normalization of tumor blood vessels by ICRF 159. A new type of drug action. Br Med J 1972;1:597-601.
23. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175:Suppl II:57-63.
24. Muthukumar N, Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for chordoma and chondrosarcoma: further experiences. Int J Radiat Oncol Biol Phys 1998;41:387-92.
25. Müller RP, Wannenmacher M, Rieck K, Schnepper E. Beitrag zur Strahlentherapie der Chordome anhand eigener Fälle und im Vergleich der Literatur. Strahlentherapie 1980;156:92-6.
26. Norpoth K, Schaphaus A, Ziegler H, Witting U. Combined treatment of the Walker tumor with radiotherapy and ICRF 159. Z Krebsforsch 1974;82:328.
27. Osborne AG. Diagnostic neuroradiology. St. Louis-Boston-Chicago: Mosby, 1994:502.
28. Rhomberg W, Hassenstein EOM, Gefeller D. Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas. Final results of a randomized study. Int J Radiat Oncol Biol Phys 1996;36:1077-84.
29. Rich TA, Schiller A, Suit HD, Mankin HJ. Clinical and pathologic review of 48 cases of chordoma. Cancer 1985;56:182-7.
30. Romero J, Cardenes H, la Torre A, Valcarcel F, Magallon R, Regueiro C, Aragon G. Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 1993;29:27-32.
31. Ryall RDH, Bates T, Newton KA, Hellmann K. Combination of radiotherapy and Razoxane (ICRF 159) for chondrosarcoma. Cancer 1979;44:891-5.
32. Ryall RDH, Hanham IWF, Newton KA, Hellmann K. Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159. Cancer 1974;34: 1040-5.
33. Salsbury AJ, Burrage K, Hellmann K. Histological analysis of the antimetastatic effect of 1,2-bis (3,5-dioxopiperazinyl) propane. Cancer Res 1974;34:843-9.
34. Sharpe HBA, Field EO, Hellmann K. The mode of action of the cytostatic agent ICRF 159. Nature 1970;226:524-6.
35. Suit HD, Goitein M, Munzenrider J, Verhey L, Urie M, Gragoudas E, Koehler A, Gottschalk B, Sisterson J, Tatsuzaki H, Miralbell R. Increased efficacy of radiation therapy by use of proton beam. Strahlenther Onkol 1990;166: 40-4.
36. Tai PTH, Craighead P, Bagdon F. Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques. Cancer 1995;75:749-56.
37. Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, O'Farrell D, Lyons S, Munzenrider J. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 1999;45:351-8.
38. York JE, Kaczaraj A, Abi-Said D, Fuller GN, Skibber JM, Janjan NA, Gokaslan ZL. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 1999;44:74-9.